Skip to Content
Print

Votrient Alternatives Compared

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Votrient Remove Votrient from your drug comparison Sutent Remove Sutent from your drug comparison Inlyta Remove Inlyta from your drug comparison
View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Votrient pazopanib Remove Votrient from your drug comparison Sutent sunitinib Remove Sutent from your drug comparison Inlyta axitinib Remove Inlyta from your drug comparison

Prescribed for Soft Tissue Sarcoma, Renal Cell Carcinoma. Votrient may also be used for purposes not listed in this medication guide.

Sutent is an oral tablet that may be taken once daily to treat certain types of RCC and other advanced cancers. It may be taken every day or on a 4 weeks on, 2 weeks off schedule. It has been... View more

Prescribed for Renal Cell Carcinoma. Inlyta may also be used for purposes not listed in this medication guide.

Prescription only

Prescription only

Prescription only

Ratings & Reviews

View all 77 reviews

View all 29 reviews

View all 1 reviews

Drug Class

Side Effects

Common side effects include: bleeding tendency disorder, abdominal pain, decreased serum glucose, decreased serum magnesium, decreased serum phosphate, diarrhea, fatigue, hypertension, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, increased serum bilirubin, leukopenia, nausea, neutropenia, thrombocytopenia, vomiting, anorexia.

See the full Votrient side effects document.

Common side effects include: oral candidiasis, asthenia, decreased left ventricular ejection fraction, diarrhea, hypokalemia, lymphocytopenia, mucositis, neutropenia, vomiting, hypertension.

See the full Sutent side effects document.

Common side effects include: headache, hypertension, hypothyroidism, increased serum alanine aminotransferase, proteinuria.

See the full Inlyta side effects document.

Pricing and Coupons

* Prices are without insurance
Quantity 120 tablet
Dosage 200 mg
Per Unit* $126.72
Cost* $15,206.71

View all Votrient prices

Quantity 28 capsule
Dosage 12.5 mg
Per Unit* $211.33
Cost* $5,917.13

View all Sutent prices

Quantity 180 tablet
Dosage 1 mg
Per Unit* $96.50
Cost* $17,369.55

View all Inlyta prices

Get free Discount Card

Get free Discount Card

Get free Discount Card

Generic Availability

No

No

No

Dosage Form(s) Available
  • Oral tablet
  • Oral capsule
  • Oral tablet

Brand Names

N/A

N/A

N/A

Half Life

The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value.

30.9 hours

60 hours

6.1 hours

CSA Schedule**

View glossary of terms.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.

Pregnancy Category
D
Category D Positive evidence of risk

See the full Pregnancy Warnings document.
D
Category D Positive evidence of risk

See the full Pregnancy Warnings document.
D
Category D Positive evidence of risk

See the full Pregnancy Warnings document.

Drug Interactions

A total of 558 drugs are known to interact with Votrient:

  • 140 major drug interactions (509 brand and generic names)
  • 410 moderate drug interactions (1426 brand and generic names)
  • 8 minor drug interactions (24 brand and generic names)

A total of 398 drugs are known to interact with Sutent:

  • 78 major drug interactions (213 brand and generic names)
  • 318 moderate drug interactions (1146 brand and generic names)
  • 2 minor drug interactions (11 brand and generic names)

A total of 179 drugs are known to interact with Inlyta:

  • 55 major drug interactions (184 brand and generic names)
  • 103 moderate drug interactions (294 brand and generic names)
  • 21 minor drug interactions (185 brand and generic names)

Alcohol/Food/Lifestyle Interactions
  • Do not consume grapefruit or grapefruit juice during treatment with PAZOPanib unless directed... View more
  • SUNItinib may be taken with or without food. If you are receiving therapy with SUNItinib you... View more
  • Do not consume grapefruit or grapefruit juice during treatment with axitinib unless directed... View more

Disease Interactions

First Approval Date

October 19, 2009

January 26, 2006

January 27, 2012

WADA Class

View World Anti-Doping Agency classifications.

N/A

N/A

N/A

More Information

Consumer Resources

Professional Resources

Related Treatment Guide

** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Compare Drugs

To view a detailed report comparing 3 or more drugs, please sign in or register.